These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1910478

  • 21. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
    Park KY, Koh JM, Kim YI, Park HJ, Gong G, Hong SJ, Ahn IM.
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
    Prévostel C, Alvaro V, de Boisvilliers F, Martin A, Jaffiol C, Joubert D.
    Oncogene; 1995 Aug 17; 11(4):669-74. PubMed ID: 7651730
    [Abstract] [Full Text] [Related]

  • 24. Variability of Ha-ras (codon 12) proto-oncogene mutations in diverse thyroid cancers.
    Bouras M, Bertholon J, Dutrieux-Berger N, Parvaz P, Paulin C, Revol A.
    Eur J Endocrinol; 1998 Aug 17; 139(2):209-16. PubMed ID: 9724079
    [Abstract] [Full Text] [Related]

  • 25. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
    Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N.
    J Clin Invest; 1992 May 17; 89(5):1517-22. PubMed ID: 1569189
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
    Persani L, Borgato S, Lania A, Filopanti M, Mantovani G, Conti M, Spada A.
    J Clin Endocrinol Metab; 2001 Aug 17; 86(8):3795-800. PubMed ID: 11502813
    [Abstract] [Full Text] [Related]

  • 31. Ras oncogene mutations in benign and malignant thyroid neoplasms.
    Karga H, Lee JK, Vickery AL, Thor A, Gaz RD, Jameson JL.
    J Clin Endocrinol Metab; 1991 Oct 17; 73(4):832-6. PubMed ID: 1890154
    [Abstract] [Full Text] [Related]

  • 32. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
    Shi Y, Tang D, Deng J, Su C.
    Chin Med J (Engl); 1998 Oct 17; 111(10):891-4. PubMed ID: 11189233
    [Abstract] [Full Text] [Related]

  • 33. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
    Russo D, Arturi F, Schlumberger M, Caillou B, Monier R, Filetti S, Suárez HG.
    Oncogene; 1995 Nov 02; 11(9):1907-11. PubMed ID: 7478621
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors.
    Shen Y, Mamers P, Jobling T, Burger HG, Fuller PJ.
    J Clin Endocrinol Metab; 1996 Nov 02; 81(11):4159-61. PubMed ID: 8923876
    [Abstract] [Full Text] [Related]

  • 38. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
    Komminoth P, Roth J, Muletta-Feurer S, Saremaslani P, Seelentag WK, Heitz PU.
    J Clin Endocrinol Metab; 1996 Jun 02; 81(6):2041-6. PubMed ID: 8964826
    [Abstract] [Full Text] [Related]

  • 39. Genetic alterations in thyroid hyperfunctioning adenomas.
    Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, DuVillard JA, Caillou B, Monier R, Rapoport B, Filetti S.
    J Clin Endocrinol Metab; 1995 Apr 02; 80(4):1347-51. PubMed ID: 7714109
    [Abstract] [Full Text] [Related]

  • 40. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors.
    Tordjman K, Stern N, Ouaknine G, Yossiphov Y, Razon N, Nordenskjöld M, Friedman E.
    J Clin Endocrinol Metab; 1993 Sep 02; 77(3):765-9. PubMed ID: 8396579
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.